Third-party advertising puts brands on top, Down Under.
While driving proven sales results for pharma and OTC brands globally, Medifacts continues to exceed at doing the very same, back where this third-party tvc platform started two decades ago - in Australia.
Seremind, an OTC mild-anxiety treatment is the latest brand beneficiary of this trusted educative third-party voice.
“Our client’s Australian launch in 2018 was a step ahead of their global creative being ready” said Kane Wooden Buchanan Asia Pacific Director “and they wanted a tried and tested solution”.
Based on the original tvc’s sales results, Seremind’s manufacturer Menarini made the decision to air the Medifacts commercial again this year. Between March and July the brand experienced an unprecedented sales uplift of more than 80% above their baseline sales mark.
“For more than 20 years Medifacts has proven itself to be a winning formula for Australian marketers. Seremind is more proof of that, and of what can be done within tight timings and budgets” Wooden said. “It was a comparatively small investment with a big sales results. That’s testament to the sales heavy-lifting Medifacts can do”.
Seremind’s campaign consisted of a 15 second Medifacts tvc paired with a radio spot.
